Germany's Sirion Biotech Launches New U.S. Headquarters in Cambridge

Date Published02/04/2019
Author NameMark Terry
Mentions specific company case(s) of reshoring, kept from offshoring, or transplantYes

Additional Reshoring Information:

Company/Division name Sirion Biotech International
Parent companySIRION Biotech GmbH
Type of work Manufacturing
Reshoring category:Foreign Direct Investment
Year reshoring announced:2019
Year reshoring implemented or to be implemented:2019
Country(ies) from which reshored:Germany
City reshored to:Cambridge
State(s) reshored to:MA
If relevant, work nearshored to:-
Product(s) reshoredviral vectors for the life sciences industry
What domestic positive factors made reshoring more attractive?Eco-system synergies, Higher productivity, Proximity to customers/market
Find Reshoring Articles